PROKIDNEY CORP. Research And Development Expense

Quick Answer

PROKIDNEY CORP. reported Research And Development Expense of $114.12 million for the year ending 2025.

  • PROKIDNEY CORP. showed a decrease of -10.6% in Research And Development Expense from 2024 to 2025.
  • This data is from PROKIDNEY CORP.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), PROKIDNEY CORP.'s Research And Development Expense has grown by 442.4%.
  • Historical annual values: Fiscal year 2025: $114.12 million | Fiscal year 2024: $127.67 million | Fiscal year 2023: $106.71 million | Fiscal year 2022: $82.07 million | Fiscal year 2021: $46.26 million | Fiscal year 2020: $21.04 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: